Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

577.90 -2.80 (-0.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,020,218
Open 580.54
Bid (Size) 573.00 (2)
Ask (Size) 577.58 (2)
Prev. Close 580.70
Today's Range 570.35 - 585.49
52wk Range 476.49 - 1,192.54
Shares Outstanding 91,779,465
Dividend Yield 0.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cisco, ServiceNow, Truist Financial And A Health Care Stock On CNBC's 'Final Trades'
Cisco reported fourth-quarter revenue of $14.67 billion, and there was a bout of profit taking, Cerity Partners' Jim Lebenthal says. 
Via Benzinga
REGENERON PHARMACEUTICALS (NASDAQ:REGN): A Prime Value Investing Candidate with Strong Fundamentals
Discover REGN, a top value investing stock. It boasts strong fundamentals, low P/E ratios, high profitability, and solid financial health, trading below its intrinsic worth. 
Via Chartmill

Performance

YTD
-19.2%
-19.2%
1 Month
+1.1%
+1.1%
3 Month
+17.7%
+17.7%
6 Month
-15.6%
-15.6%
1 Year
-50.6%
-50.6%

More News

Read More
MongoDB To Rally Around 63%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Where Regeneron Pharmaceuticals Stands With Analysts
Via Benzinga
Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data
Via Benzinga
Regeneron Stock Rallies After Therapy For Autoimmune Disease Meets Late-Stage Trial Goals: Retail Thinks Stock Might Hit An All-Time Low Soon
Via Stocktwits
Regeneron Says FDA Will Take More Time to Review Its Two Eylea HD Submissions
Via Stocktwits
Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Top S&P500 movers in Monday's session
Via Chartmill
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
Via Benzinga
2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts
Via The Motley Fool
What's going on in today's session: S&P500 movers
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
What's going on in today's session: S&P500 movers
Via Chartmill
EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
3 of Wall Street’s Favorite Stocks with Open Questions
Via StockStory
Immuno-Oncology Stocks Q2 In Review: Incyte (NASDAQ:INCY) Vs Peers
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are moving in today's session
Via Chartmill
REGN Q2 Deep Dive: New Indications and Pipeline Progress Offset EYLEA Challenges
Via StockStory
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know
Via StockStory
Topics Bonds Economy Lawsuit
This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
Via Stocktwits
A Look Into Regeneron Pharmaceuticals Inc's Price Over Earnings
Via Benzinga
How Do Investors Really Feel About Regeneron Pharmaceuticals?
Via Benzinga
Regeneron Announces Investor Conference Presentations
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
These Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings
Via Benzinga

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 577.90
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 09/02/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 53.04B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 53B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback